Tudorza Pressair (aclidinium bromide inhalation powder) 

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) March 2016 CONTRAINDICATIONS The use of TUDORZA PRESSAIR is contraindicated in the following conditions: Severe hypersensitivity...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts